Cormorant Asset Management, LP - 29 May 2023 Form 3 Insider Report for GreenLight Biosciences Holdings, PBC (GRNA)

Role
Other*
Signature
CORMORANT ASSET MANAGEMENT, LP By: /s/ Bihua Chen, Managing Member
Issuer symbol
GRNA
Transactions as of
29 May 2023
Transactions value $
$0
Form type
3
Filing time
08 Jun 2023, 17:12:35 UTC
Previous filing
24 Apr 2023
Next filing
24 Jul 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding GRNA Common Stock 9.19M 29 May 2023 See Footnotes F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Cormorant Asset Management, LP ("Cormorant") serves as the investment manager of Cormorant Global Healthcare Master Fund, LP (the "Master Fund") and Cormorant Private Healthcare Fund II, LP ("Fund II"). Cormorant Global Healthcare GP, LLC ("GP LLC") and Cormorant Private Healthcare GP II, LLC ("GP II") serve as General Partner of the Master Fund and Fund II, respectively. Bihua Chen serves as manager of Cormorant, GP LLC and GP II. Each of the Reporting Persons disclaims beneficial ownership of the shares reported herein except to the extent of its or her pecuniary interest therein, and the filing of this Form 3 shall not be construed as an admission that any of the Reporting Persons is the beneficial owner of any such shares for purposes of Section 16(a) of the Securities Exchange Act of 1934 or for any other purpose.
F2 Represents (i) 4,751,020 shares of Common Stock beneficially owned by the Master Fund and (ii) 4,437,639 shares of Common Stock beneficially owned by Fund II.

Remarks:

The Reporting Persons may be deemed to be members of a "group" (within the meaning of Section 13(d)(3) of the Securities Exchange Act of 1934) of persons that, in the aggregate, beneficially own over 10% of the Issuer's Common Stock.